Download now
Research from Analysis Paper:
Accounting Study course Concepts
Olympus Corporation
Company Overview
With sales of $10. 6th billion intended for the financial year concluded March 23, 2011, Olympus Corporation (hereinafter alternatively “Olympus” or “the company”), can be described as leading manufacturer of endoscopic medical equipment, cameras and also other sophisticated the image devices, microscopes, and information and sales and marketing communications equipment (Verschoor, 2012). Based on the company’s business profile, Olympus Corporation competes in medical, life science, industrial plus the imaging groups (Business account, 2014). At the moment, Olympus Company competes in five principal business sectors as follows:
The Medical portion offers medical endoscopes, surgical endoscopes, ultrasound endoscopes and more.
The Life and Industry section provides natural microscopes, professional microscopes, industrial endoscopes and nondestructive screening equipment.
The Video segment delivers digital cameras and sound saving machines.
four. The Others part is involved in the supply of biomaterials, and the advancement systems.
a few. The Common section mainly consists of in having investment and financial investment (Business account, 2014).
By March 23, 2013, the Company had 174 subsidiaries and five associated companies (Business profile, 2014).
The company’s current major business lines range from the following:
1 . Endoscopes: Endoscopic video imaging systems, medical information devices, fiberscope devices, broncho endoscope systems, endoscopic ultrasound devices; ultrasound probes; ultrasound centers; capsule endoscopy systems; washing, disinfecting and sterilization devices; medical treatment peripherals; ancillary items.
2 . Endosurgery: Endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, anesthesiology and otolaryngology; treatment and medical equipment; peripherals.
3. Endotherapy: Endotherapy goods.
4. Digital camera models: Interchangeable lens system digicams, compact digital digital cameras, digital camera items.
5. Optical components: Lens barrels to get digital cameras, optical materials.
six. Audio: IC recorders.
several. Binoculars: Goggles (Business review, 2014).
The Accounting Difficulty:
A number of huge payments that have been made to purported financial advisors concerning the 08 purchase of Gyrus Group, a U. K. medical unit manufacturer, and the acquisition of three other Japan companies were viewed by outsiders and investors as suspect (Verschoor, 2012).
The payments of $687 million (approximately one-third of the cost from the entire Gyrus acquisition) were estimated as the largest combination and obtain fee ever paid to consultants. The payments were created to a Cayman Islands special purpose investment vehicle that vanished shortly after receiving the final payment (purportedly a U. S. brokerage home and its subsidiary) for the acquisition of Gyrus and the various other entities; yet , as offered by the company, these repayments were not specifically illegal beneath Japanese legislation. The information concerning the payments was revealed within an investigation simply by PricewaterhouseCoopers. A great Olympus pr release dated March 19, 2009 emphasized that, “By unanimous resolution of the board of corporate auditors, their conclusion is that, ‘No dishonesty or perhaps illegality can be found in the transaction itself, nor any breach of responsibility to very good management or any type of systematic errors by the directors recognized'” (cited in Verschoor, 2012, p. 13). Additionally , an Olympus audit plank commissioned last season conducted a study concerning the consultant payments and failed to discover any illegality in the purchase (Verschoor, 2012).
Nevertheless, the resulting repercussion erased $3. 2 billion dollars off Olympus’s share worth and “its reputation intended for ethics took place the same tube” (Verschoor, 2012, p. 14). In response to mounting calls for accountability from Japanese and U. H. institutional shareholders, Oympus declared on November 1, 2011, that it experienced appointed a third-party exceptional
